Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either Agent Alone-Reference-Cited by-同舟云学术

Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either Agent Alone

Published:2017-02 Issue:2 Volume:23 Page:255-261
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Al-Homsi Ahmad Samer,Goodyke Austin^ORCID,McLane Michael,Abdel-Mageed Sarah,Cole Kelli,Muilenburg Marlee,Feng Yuxin

Funder

Spectrum Foundation

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Hematopoietic cell transplantation at 50;Appelbaum;N Engl J Med,2007

2. Acute graft-versus-host disease: a bench to bedside update;Holtan;Blood,2014

3. Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study;Remberger;Biol Blood Marrow Transplant,2011

4. Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low dose total body irradiation, and posttransplantation cyclophosphamide;Luznik;Blood,2001

5. High-dose, posttransplantation cyclophosphamide to promote graft-host tolerance after hematopoietic stem cell transplantation;Luznik;Immunol Rev,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment;Biomedicine & Pharmacotherapy;2022-04

2. Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease;Bone Marrow Transplantation;2021-09-23

3. LMP7 polymorphism may modify the presentation and clinical impact of minor histocompatibility antigens in matched related hematopoietic stem cell transplantation;Cellular Immunology;2021-06

4. Protecting Intestinal Microenvironment Alleviates Acute Graft-Versus-Host Disease;Frontiers in Physiology;2021-02-12

5. Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplant;Blood Advances;2020-08-10